Optimization of patient and site engagement in the SYNCHRONIZE™ phase 3 clinical trial program for survodutide in obesity through clinical trial simulation

20260 citationsJournal Articlegold Open Access

Authors

Domenica M. Rubino · Washington Center for Weight Management and Research

Vicki Mooney · European Foundation for the Improvement of Living and Working Conditions

V. Van de Walle · Mining and Metallurgy Institute Bor

David Baanstra · Boehringer Ingelheim (Netherlands)

Wouter Daniëls · Boehringer Ingelheim (Netherlands)

Christopher Recaldin

Joe Nadglowski · Immunization Action Coalition

Abstract

These results suggest participant and site staff input from a CTS could help improve obesity clinical trial design, which may ultimately lead to more robust data and reliable clinical findings.

Topics & Keywords

Diabetes Treatment and Management Bariatric Surgery and Outcomes Pharmacology and Obesity Treatment

Publication Details

Published in: Contemporary Clinical Trials Communications

Volume 49, pp. 101611-101611

DOI: 10.1016/j.conctc.2026.101611

Field-Weighted Citation Impact: 0.00

Command Palette

Optimization of patient and site engagement in the SYNCHRONIZE™ phase 3 clinical trial program for survodutide in obesity through clinical trial simulation

Authors

Abstract

Topics & Keywords

Publication Details